Johnson & Johnson (JNJ) operating KPIs
JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3043% above fair value
$273.20−2.00 (-0.73%)
Close on Oct 30, 2026Market cap $658.38BP/E 31.7Yield 1.88%
Johnson & Johnson gAAP gross profit ($M) ($M)
Form 8-K EX-99.2 Condensed Consolidated Statement of Earnings
Latest, Q3 2026
17,302
Period ended Sep 30, 2026
Change on a year earlier
+3.7%
16,690 in Q3 2025
History
38 quarters
Since Q2 2017
Sources
34
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up gaap gross profit ($m)
- GAAP gross profit margin (% to sales)68.1% · Q3 2026
- Cost of products sold (% to sales)31.9% · Q3 2026
- Selling, marketing and administrative expenses (% to sales)24.7% · Q3 2026
- Research and development expense (% to sales)18.3% · Q3 2026
- GAAP earnings before provision for taxes (% to sales)0.1% · Q3 2026
- GAAP net earnings margin (% to sales)0.8% · Q3 2026
Cite this data
StockData. (2026). Johnson & Johnson GAAP gross profit ($M) ($M), quarterly Q2 2017–Q3 2026 [Data set]. Compiled from Johnson & Johnson SEC filings and investor materials. https://stockdatahq.com/stocks/jnj/kpis/gaap_gross_profit_sched
See every metric in the Johnson & Johnson KPI table. Data updated Oct 25, 2026.